CRF receptor-1 antagonism mitigates Aβ pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease

INTRODUCTION: Stress and corticotropin-releasing factor (CRF) have been implicated as mechanistically involved in Alzheimer’s disease (AD), but agents that impact CRF signaling have not been carefully tested for therapeutic efficacy or long term safety in animal models. METHODS: To test whether anta...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement
Auteurs principaux: Zhang, Cheng, Kuo, Ching-Chang, Moghadam, Setareh H., Monte, Louise, Campbell, Shannon N., Rice, Kenner C., Sawchenko, Paul E., Masliah, Eliezer, Rissman, Robert A.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4860182/
https://ncbi.nlm.nih.gov/pubmed/26555315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2015.09.007
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires